IMEMR
EMRO
66.92
Index Copernicus
ICICICICICICICIC
Volume 5, Issue 4 (2024)
J Clinic Care Skill 2024, 5(4): 207-213 |
Back to browse issues page
Article Type:
Subject:
History
Received: 2024/09/9 | Accepted: 2024/12/18 | Published: 2024/12/21
Received: 2024/09/9 | Accepted: 2024/12/18 | Published: 2024/12/21
How to cite this article
Yeganeh M, Ahmadi H, salmani F, Goli S. Role of Nurses in Prevention From Potential Drug Interactions in the Intensive Care Unit. J Clinic Care Skill 2024; 5 (4) :207-213
URL: http://jccs.yums.ac.ir/article-1-290-en.html
URL: http://jccs.yums.ac.ir/article-1-290-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rights and permissions
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
1- Nursing & Midwifery Sciences Development Research Center, Najafabad Branch, Islamic Azad University, Najafabad, Iran
Abstract (325 Views)
Aims: Drug interactions include chemical reactions that often occur between two or more drugs or even when a drug is taken with food, drink, or a supplement. Therefore, the aim of this current review is the determine potential drug interactions in the intensive care unit and the role of nurses in their prevention.
Information & Methods: This is an integrated review. Our available sources include all studies conducted on drug interactions in elderly care units between 2012 and 2024 that are included in this study. The databases searched include: CINAHL, Scopus, PubMed, Cochrane Database of Systematic Reviews, Wiley, Science Direct, Iran Medex, Scientific Information Database (SID), and Google Scholar. The Persian-English keywords were "drug interactions", "potential drug interactions", “adverse events", “intensive care units", “critically units", “risk of drug coexistence”, “drug accident”, “adult” and “elderly”.
Findings: Using the relevant keywords, 34 studies were found. 17 articles were excluded due to the lack of relevance to the topic and unavailability of the full text of the article. Finally, 12 valid articles were confirmed, of which 6 were Persian articles and 6 were in English.
Conclusion: Drug interactions have a direct relationship with low Apgar scores, age, long-term stays in the department, and the number of doctors. Phenytoin, phenobarbital, and fentanyl are identified as the most interfering in the department.
Information & Methods: This is an integrated review. Our available sources include all studies conducted on drug interactions in elderly care units between 2012 and 2024 that are included in this study. The databases searched include: CINAHL, Scopus, PubMed, Cochrane Database of Systematic Reviews, Wiley, Science Direct, Iran Medex, Scientific Information Database (SID), and Google Scholar. The Persian-English keywords were "drug interactions", "potential drug interactions", “adverse events", “intensive care units", “critically units", “risk of drug coexistence”, “drug accident”, “adult” and “elderly”.
Findings: Using the relevant keywords, 34 studies were found. 17 articles were excluded due to the lack of relevance to the topic and unavailability of the full text of the article. Finally, 12 valid articles were confirmed, of which 6 were Persian articles and 6 were in English.
Conclusion: Drug interactions have a direct relationship with low Apgar scores, age, long-term stays in the department, and the number of doctors. Phenytoin, phenobarbital, and fentanyl are identified as the most interfering in the department.
Keywords:
References
1. Malki MA, Pearson ER. Drug-drug-gene interactions and adverse drug reactions. Pharmacogenomics J. 2020;20(3):355-66. [Link] [DOI:10.1038/s41397-019-0122-0]
2. Mehrpooya M, Taher A, Golgiri A, Mohammadi Y, Ahmadimoghaddam D. Evaluation of the drug interactions frequency and their related factors in hospitalized patients of the intensive care unit in the Hamadan Besat Hospital. Avicenna J Nurs Midwifery Care. 2021;29(3):171-80. [Persian] [Link] [DOI:10.30699/ajnmc.29.3.171]
3. Askari M, Eslami S, Louws M, Wierenga PC, Dongelmans DA, Kuiper RA, et al. Frequency and nature of drug‐drug interactions in the intensive care unit. Pharmacoepidemiol Drug Saf. 2013;22(4):430-7. [Link] [DOI:10.1002/pds.3415]
4. Buğday MS, Öksüz E. Drug-drug interactions in the risky population: Elderly, urological patients admitted to the intensive care unit. East J Med. 2021;26(2):236-41. [Link] [DOI:10.5505/ejm.2021.04864]
5. Vaismoradi M, Tella S, A Logan P, Khakurel J, Vizcaya-Moreno F. Nurses' adherence to patient safety principles: A systematic review. Int J Environ Res Public Health. 2020;17(6):2028. [Link] [DOI:10.3390/ijerph17062028]
6. Rodrigues AT, Stahlschmidt R, Granja S, Falcao AL, Moriel P, Mazzola PG. Clinical relevancy and risks of potential drug-drug interactions in intensive therapy. Saudi Pharm J. 2014;23(4):366-70. [Link] [DOI:10.1016/j.jsps.2014.11.014]
7. Janković SM, Pejčić AV, Milosavljević MN, Opančina VD, Pešić NV, Nedeljković TT, et al. Risk factors for potential drug-drug interactions in intensive care unit patients. J Crit Care. 2018;43:1-6. [Link] [DOI:10.1016/j.jcrc.2017.08.021]
8. Kardas P, Urbański F, Lichwierowicz A, Chudzyńska E, Czech M, Makowska K, et al. The prevalence of selected potential drug-drug interactions of analgesic drugs and possible methods of preventing them: Lessons learned from the analysis of the real-world national database of 38 million citizens of Poland. Front Pharmacol. 2021;11:607852. [Link] [DOI:10.3389/fphar.2020.607852]
9. Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, et al. Clinical practice guideline: Safe medication use in the ICU. Crit Care Med. 2017;45(9):e877-915. [Link] [DOI:10.1097/CCM.0000000000002533]
10. Carollo M, Crisafulli S, Selleri M, Piccoli L, L'Abbate L, Trifirò G. Agreement of different drug-drug interaction checkers for proton pump inhibitors. JAMA Netw Open. 2024;7(7):e2419851. [Link] [DOI:10.1001/jamanetworkopen.2024.19851]
11. Łój P, Olender A, Ślęzak W, Krzych Ł. Pharmacokinetic drug-drug interactions in the intensive care unit-Single-centre experience and literature review. Anaesthesiol Intensive Ther. 2017;49(4):259-67. [Link]
12. Kovačević M, Vezmar Kovačević S, Radovanović S, Stevanović P, Miljković B. Potential drug-drug interactions associated with clinical and laboratory findings at hospital admission. Int J Clin Pharm. 2020;42(1):150-7. [Link] [DOI:10.1007/s11096-019-00951-y]
13. Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, et al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532. [Link] [DOI:10.1136/bmj.k3532]
14. Isbister GK, Page CB. Drug induced QT prolongation: The measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol. 2013;76(1):48-57. [Link] [DOI:10.1111/bcp.12040]
15. Mouton JP, Mehta U, Parrish AG, Wilson DP, Stewart A, Njuguna CW, et al. Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: A cross‐sectional survey. Br J Clin Pharmacol. 2015;80(4):818-26. [Link] [DOI:10.1111/bcp.12567]
16. Hansten PD, Tan MS, Horn JR, Gomez-Lumbreras A, Villa-Zapata L, Boyce RD, et al. Colchicine drug interaction errors and misunderstandings: Recommendations for improved evidence-based management. Drug Saf. 2023;46(3):223-42. [Link] [DOI:10.1007/s40264-022-01265-1]
17. Nabovati E, Vakili-Arki H, Taherzadeh Z, Hasibian MR, Abu-Hanna A, Eslami S. Drug-drug interactions in inpatient and outpatient settings in Iran: A systematic review of the literature. DARU J Pharm Sci. 2014;22:52. [Link] [DOI:10.1186/2008-2231-22-52]
18. Mosahneh A, Ahmadi B, Akbarisari A, Rahimi Foroshani A. Assessing the causes of medication errors from the nurses' viewpoints of hospitals at Abadan City in 2013. J Hosp. 2016;15(3):41-51. [Persian] [Link]
19. Mohammadi E, Salmani F. The practices and barriers to adult visiting in intensive care units: An integrated review. Nurs Midwifery J. 2020;17(10):780-809. [Persian] [Link]
20. Bowling A. Research methods in health: Investigating health and health services. New York: McGraw-Hill Education; 2014. [Link]
21. Rafiei H, Esmaeili Abdar M, Moghadasi J. The prevalence of potential drug interactions among critically ill elderly patients in the intensive care unit (ICU). SALMAND Iran J Ageing. 2012;6(4):14-9. [Persian] [Link]
22. Azimi M, Sanagoo A, Joybari L. The potential drug interactions in pediatric intensive care unit: A case study from Imam Hossein hospital in Isfahan. J Pediatr Nurs. 2015;1(4):45-51. [Persian] [Link]
23. Uijtendaal EV, Van Harssel LL, Hugenholtz GW, Kuck EM, Zwart‐van Rijkom JE, Cremer OL, et al. Analysis of potential drug‐drug interactions in medical intensive care unit patients. Pharmacotherapy. 2014;34(3):213-9. [Link] [DOI:10.1002/phar.1395]
24. Alvim MM, Silva LA, Leite IC, Silvério MS. Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital. REVISTA BRASILEIRA DE TERAPIA INTENSIVA. 2015;27:353-9. [Portuguese] [Link] [DOI:10.5935/0103-507X.20150060]
25. Rafati M, Nakhshab M, Irvash M, Rabiee T. Drug interactions in neonatal intensive critical care unit in Bu-Ali Sina Teaching Hospital, Sari, Iran. J Mazandaran Univ Med Sci. 2016;25(133):305-9. [Persian] [Link]
26. Eishi Oskuyi A, Valizad Hasanloui MA, Badavi SK, Bahrami Bokani M, Sharifi H. Evaluation of drug-drug interactions in cancer patients admitted to ICU of Imam Khomeiny hospital-Urmia at 2014-2015. Stud Med Sci. 2017;28(3):215-22. [Persian] [Link]
27. Rodrigues AT, Stahlschmidt R, Granja S, Pilger D, Falcão AL, Mazzola PG. Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital. Braz J Pharm Sci. 2017;53:e16109. [Link] [DOI:10.1590/s2175-97902017000116109]
28. Fernandes FM, Da Silva Paulino AM, Sedda BC, Da Silva EP, Martins RR, Oliveira AG. Assessment of the risk of QT-interval prolongation associated with potential drug-drug interactions in patients admitted to intensive care units. Saudi Pharm J. 2019;27(2):229-34. [Link] [DOI:10.1016/j.jsps.2018.11.003]
29. Bakker T, Abu-Hanna A, Dongelmans DA, Vermeijden WJ, Bosman RJ, De Lange DW, et al. Clinically relevant potential drug-drug interactions in intensive care patients: A large retrospective observational multicenter study. J Crit Care. 2021;62:124-30. [Link] [DOI:10.1016/j.jcrc.2020.11.020]
30. Costa HT, Leopoldino RW, Da Costa TX, Oliveira AG, Martins RR. Drug-drug interactions in neonatal intensive care: A prospective cohort study. Pediatr Neonatol. 2021;62(2):151-7. [Link] [DOI:10.1016/j.pedneo.2020.10.006]
31. Ötles S, Senturk A. Food and drug interactions: A general review. ACTA SCIENTIARUM POLONORUM TECHNOLOGIA ALIMENTARIA. 2014;13(1):89-102. [Link] [DOI:10.17306/J.AFS.2014.1.8]
32. El Lassy RBM, Ouda MM. The effect of food-drug interactions educational program on knowledge and practices of nurses working at the pediatric out-patients' clinics in El-Beheira general hospitals. J Nurs Health Sci. 2019;8(4):34-48. [Link]
33. Hughes JE, Waldron C, Bennett KE, Cahir C. Prevalence of drug-drug interactions in older community-dwelling individuals: A systematic review and meta-analysis. Drugs Aging. 2023;40(2):117-34. [Link] [DOI:10.1007/s40266-022-01001-5]
34. Brabcová I, Hajduchová H, Tóthová V, Chloubová I, Červený M, Prokešová R, et al. Reasons for medication administration errors, barriers to reporting them and the number of reported medication administration errors from the perspective of nurses: A cross-sectional survey. Nurse Educ Pract. 2023;70:103642. [Link] [DOI:10.1016/j.nepr.2023.103642]
35. Skidmore-Roth L. Mosby's 2021 nursing drug reference. Maryland Heights: Mosby; 2020. [Link]
36. Manias E, Kusljic S, Wu A. Interventions to reduce medication errors in adult medical and surgical settings: A systematic review. Ther Adv Drug Saf. 2020;11:2042098620968309. [Link] [DOI:10.1177/2042098620968309]
37. Rohde E, Domm E. Nurses' clinical reasoning practices that support safe medication administration: An integrative review of the literature. J Clin Nurs. 2018;27(3-4):e402-11. [Link] [DOI:10.1111/jocn.14077]
38. Neamțu M, Bild V, Ababei DC, Rusu RN, Moșoiu C, Neamțu A. The impact of inflammation and drug interactions on Covid-19 pharmacotherapy. A mini-review. FARMACIA. 2022;70(5):775-84. [Link] [DOI:10.31925/farmacia.2022.5.2]
39. Yeganeh M, Salmani F. Missed nursing care and its associated factors: An integrative review. Med Surg Nurs J. 2023;12(3):e148232. [Link] [DOI:10.5812/msnj-148232]
40. McCuistion LE, DiMaggio KV, Winton MB, Yeager JJ. Pharmacology: A patient-centered nursing process approach. Netherlands: Elsevier; 2021. [Link]
41. Lo SY, Reeve E, Page AT, Zaidi ST, Hilmer SN, Etherton-Beer C, et al. Attitudes to drug use in residential aged care facilities: A cross-sectional survey of nurses and care staff. Drugs Aging. 2021;38(8):697-711. [Link] [DOI:10.1007/s40266-021-00874-2]